10 Horror Movies That Flopped Hard In 2025

The biggest horror movie flops of the year.

M3gan 2.0
Blumhouse

2025 has been another great year for the horror genre, with many offerings scaring up a storm at the box office, with the likes of The Conjuring: Last Rites, Sinners, Final Destination: Bloodlines, Weapons, 28 Years Later, and Black Phone 2 ranking among the highest-grossing films of the last 12 months.

But not all movies can be box office juggernauts, of course, and so there are always going to be those ones that, for one of many reasons, end up flopping commercially. And despite horror being one of the most commercially reliable of all genres, it's as true here as it is anywhere else - films flop, no matter whether they're good or bad.

In 2025, the following are the horror movies that flopped the most catastrophically, brutally performing below expectations, and perhaps even wiping out future franchise prospects in the process. Maybe the vibes of the marketing were off, the distributor sent it out to die, or it just wasn't that good, but whatever the reason, these horror films all failed theatrically, leaving them to try and recoup the rest of their budgets on streaming.

10. Wolf Man

Wolf Man
Blumhouse

On paper, it seemed like a new take on Universal's Wolf Man had a ton of commercial potential, especially with Leigh Whannell serving as co-writer and director, following up his 2020 smash hit reimagining of The Invisible Man. And armed with an impressively sleek $25 million budget - just a fraction of the $150 million price tag afforded to 2010's Benicio del Toro-starring remake - it frankly seemed like it couldn't fail.

However, Wolf Man ended up grossing just $35.2 million globally, which is a disastrous result for a film with such recognisable branding from a hugely successful genre filmmaker. It wasn't exactly a huge shock, though, given that Universal sent the picture out to die this past January with mediocre marketing, while lifting the review embargo just two days before release.

Critics were heavily split on Wolf Man, and a "C-" CinemaScore confirmed it didn't bowl over general audiences either. 

When a property that's all about a grotesque transformation largely shies away from focusing on said transformation, it's not terribly surprising that audiences stayed away, especially as Robert Eggers' Nosferatu was still feasting on the box office at the time.


9. Heart Eyes

Heart Eyes
Screen Gems

Heart Eyes is another movie that seemingly had everything it needed to at least be a modest hit.

With its uniquely Valentine's Day-themed slasher premise, this seemed to offer a perfect counter-programming alternative to the usual saccharine rom-coms released mid-February. And on top of this, Josh Ruben's film also released to positive reviews from critics alongside a pretty-good "B-" CinemaScore from audiences.

Ultimately, Heart Eyes failed to gross even double its lean $18 million budget, topping out at just $33.1 million globally.

This was said to be a result of the film underperforming with couples, with only 40% of opening weekend audiences attending a screening with a partner. It didn't help that Heart Eyes tanked overseas, too, making over 90% of its box office revenue in the U.S., and some also suggested that the marketing failed to sufficiently convey the movie's genre-bending tone.

The silver lining, however, is that Heart Eyes has a good chance of becoming a cult hit on streaming, even as a mainstay that horror fans will revisit every single February 14th.


8. Opus

Ayo Edebiri - Opus
A24

A24 certainly knows how to sell and release a commercially successful horror film, and it was easy to be intrigued by Opus, a compellingly premised horror-thriller starring The Bear's Ayo Edebiri and boasting a killer ensemble cast including John Malkovich, Juliette Lewis, Murray Bartlett, Amber Midthunder, and Tony Hale.

Even with a tiny $10 million budget, though, Opus was a catastrophic flop, grossing a pitiful $2.2 million globally.

While projected to gross up to $4 million in its opening weekend, Opus ended up making just $1 million, leaving it sat outside the top 10 before it fell off a cliff and dropped a brutal 72.7% in its second weekend.

There are a few obvious issues here; Opus premiered to mixed reviews at Sundance six weeks before it came out, and the marketing failed to really sell its satirical throughline, largely just making it look like a less-good version of Get Out. A meagre international release didn't help either, with the film grossing just $203,196 outside of the U.S.


7. Him

Him
Universal

Sports-themed horror Him had one major thing working in its favour: the association of Jordan Peele, who produced the film and whose name was plastered all over its slick marketing.

Not unlike Opus, Him was clearly sold as a Get Out-adjacent satire, with Universal almost certainly hoping that casual audiences would assume that Peele directed it rather than rising filmmaker Justin Tipping.

Despite plenty of pre-release anticipation in the horror community, Him ended up grossing just $28 million, a mere hair higher than its $27 million production budget. The review embargo lifted just a day before release, and critical reception was mostly negative, save for some scattered praise for Marlon Wayans' performance.

For many, it seemed like the marketing just didn't connect. There was an assumption that Him was about traumatic brain injuries in contact sports, but that wasn't really its target at all. Ultimately, a horror film centered around American football is a pretty niche concoction, especially where international markets are concerned, but even so, this was a uniquely poor performance.


6. Death of a Unicorn

Death of a Unicorn
A24

Opus wasn't A24's only horror dud this year, and their other one was considerably more surprising.

Death of a Unicorn had one hell of a wild concept, which was easily sold through its title and trailers, while the cast was led by the ultra-popular likes of Jenna Ortega and Paul Rudd. And despite its heightened premise, it was budgeted at just $15 million.

Even with so much going for it, though, the horror-comedy topped out at a paltry $16.1 million. 

This likely speaks mostly to the aggressively mixed response from critics and audiences alike, many feeling that Death of a Unicorn neither fully succeeded as a horror or as a comedy. It's also yet further proof that stars simply don't have the pulling power to open a movie on name alone anymore - save for the outliers like Tom Cruise and Leonardo DiCaprio.

Word-of-mouth here wasn't awful, but it just wasn't good enough to persuade folk to leave the house, and so within two weekends its business was done.


5. The Woman in the Yard

the woman in the yard
Blumhouse

Blumhouse has had a wildly mixed bag of a 2025, defined by unexpected flops and a few bread-and-butter hits like Black Phone 2 and Five Nights at Freddy's 2.

One of the studio's more surprising duds this year was The Woman in the Yard, a $12 million psychological horror film with an easy-to-market premise, made by a director with a string of genre hits to his name, Jaume Collet-Serra (Unknown, Non-Stop, The Shallows). Even so, it grossed just $23.3 million globally, falling a tad shy of the 2x multiplier needed to fully cover its costs.

Mixed-to-negative reviews didn't help, nor a not-great "C-" CinemaScore, and it probably further hurt the movie that cinema is arguably wildly oversaturated with horror movies about grief at the moment. This was less the "fun" B-movie folk might expect from the title and trailers, and instead a more earnest, serious-minded horror that many likely decided to catch on streaming instead - if at all.


4. Keeper

Keeper 2025
Neon

Osgood Perkins enjoyed impressive back-to-back hits with last year's Longlegs and The Monkey earlier this year, and while his new film Keeper didn't have as nearly a multiplex-friendly premise, it still seemed likely to offer a decent return on its tiny $6 million budget.

Despite a tantalising, vibes-heavy marketing campaign, Keeper grossed just $2.5 million in its U.S. opening weekend, and to date has made only $5 million worldwide, not even covering its cost of production.

The review embargo lifted a day before release - sensing a pattern here? - and was extremely mixed. It also landed a brutal "D+" CinemaScore from audiences, adding up to a near-total rejection from all but the most committed fans of Perkins' work.

It's entirely possible that Keeper's vague marketing didn't really land for mainstream audiences either, but at least the low budget will keep Neon's losses relatively small. If the cost of keeping Perkins happy is helping him make a "one for me" film with limited commercial appeal, then it's probably worth it to Neon.


3. The Toxic Avenger

The Toxic Avenger
Iconic Events Releasing

Honestly, the fact that The Toxic Avenger got released at all basically feels like a minor miracle, let alone that Cineverse unleashed it in almost 2,000 U.S. cinemas.

After all, back in the summer of 2024, the superhero horror remake was deemed "unreleasable" due to its "out there" nature, no matter that it had already premiered at festivals to solid reviews in late 2023.

It finally hit cinemas this past August, though, and while the budget of the Peter Dinklage-led film has never been publicly revealed, it was clearly higher than its mere $3.4 million box office total.

Let's be real here: The Toxic Avenger is an extremely niche IP even within horror fandom, and the marketing made basically zero attempt to appeal to younger folk who know nothing about the original movie. It was never going to make bank at the box office, and will now exist on streaming as a curio for fans of grindhouse-flavoured schlock to discover for themselves.


2. M3GAN 2.0

M3GAN 2.0
Universal

And now we come to the single most surprising horror flop of the entire year, M3GAN 2.0.

The original killer android movie was a surprise hit at the start of 2023, grossing an astonishing $181.8 million against a mere $12 million budget, ensuring that Blumhouse swiftly greenlit a sequel.

M3GAN 2.0 arrived with a much heftier $25 million budget, but considering the enduring viral success of the title character, it just didn't seem like this sequel could fail.

But, oh, how wrong we were, as M3GAN 2.0 ended up grossing just $39.1 million - barely 20% of the original's global total.

As for what happened? A big problem here is that M3GAN 2.0 isn't really a horror movie at all. Instead, the filmmakers opted to ambitiously shift the tone to sci-fi comedy, but this evidently wasn't the vibe that most fans of the original were interested in. And so they largely stayed home, with producer Jason Blum even later admitting that he and those involved "got too excited" by believing that fans would follow M3GAN to a new genre.

And like that, a cash cow with the potential for innumerable smash hit sequels was abruptly killed off.


1. Ash

ash eiza gonzalez
RLJE

Ash is the new film from Flying Lotus (Kuso), and though sold with a couple of trippy trailers touting an intense two-hander between Eiza González and Aaron Paul, it was dead on arrival.

Though broadly well-received by critics following its premiere at SXSW, Ash fell short of even meagre industry projections, grossing less than $700k in its opening weekend, far from the expected $2 million. Even though it was released in barely 1,000 U.S. cinemas, that's rough, and by the end of its brief theatrical run, it totted up just $1.1 million in receipts.

While we don't know how much Ash actually cost, it clearly wasn't super cheap, given the elaborate visual effects and name actors, so it faces quite the steep climb to recoup its budget on streaming.

As for why it flopped? Cosmic horror is a tough sell to mainstream genre fans at the best of times, and between the low-key cinema release and so-so marketing, it never really had much of a chance to break out.


 
Posted On: 
Contributor
Contributor

Stay at home dad who spends as much time teaching his kids the merits of Martin Scorsese as possible (against the missus' wishes). General video game, TV and film nut. Occasional sports fan. Full time loon.